ArticleBiomedicines2023

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations.

Anthony Tarabay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.